Safety of the Synthetic Retinoid Fenretinide: Long-Term Results From a Controlled Clinical Trial for the Prevention of Contralateral Breast Cancer
- 15 March 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (6) , 1664-1670
- https://doi.org/10.1200/jco.2001.19.6.1664
Abstract
PURPOSE: To describe the pattern of occurrence of adverse events commonly arising during treatment with fenretinide, a synthetic retinoid under investigation for cancer prevention. PATIENTS AND MET...Keywords
This publication has 15 references indexed in Scilit:
- Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast CancerJNCI Journal of the National Cancer Institute, 1999
- Cancer Chemoprevention: Progress and PromiseJNCI Journal of the National Cancer Institute, 1998
- Chemoprevention Trial of Contralateral Breast Cancer with Fenretinide. Rationale, Design, Methodology, Organization, Data Management, Statistics and AccrualTumori Journal, 1997
- Long-term effects of fenretinide on retinal functionEuropean Journal Of Cancer, 1997
- Risks and Benefits of Retinoids in the Chemoprevention of CancerDrug Safety, 1995
- Assessment of Vitamin A Status by a Disk Applicator for Conjunctival Impression CytologyArchives of Ophthalmology (1950), 1990
- Teratogenicity of N‐(4‐hydroxyphenyl) ‐all‐trans‐retinamide in rats and rabbitsTeratogenesis, Carcinogenesis, and Mutagenesis, 1988
- Lack of genotoxicity of the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamideFundamental and Applied Toxicology, 1985
- Retinoids and Chemoprevention of CancerPublished by Springer Nature ,1981
- Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1980